Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TCC”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Early research (Phase 1)UnknownNCT04147182
What this trial is testing

Perioperative Intravesical Instilation of Hypertonic Saline Following Bladder Tumor Resection

Who this might be right for
TCC
Dan Leibovici 15
Testing effectiveness (Phase 2)Study completedNCT00714025
What this trial is testing

A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy

Who this might be right for
Transitional Cell Carcinoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 40
Early research (Phase 1)Ended earlyNCT02437916
What this trial is testing

Safety Study of AMG 228 to Treat Solid Tumors

Who this might be right for
Advanced MalignancyAdvanced Solid TumorsCancer+8 more
Amgen 30
Large-scale testing (Phase 3)UnknownNCT00949455
What this trial is testing

A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium

Who this might be right for
Bladder Cancer
Queen Mary University of London 204
Testing effectiveness (Phase 2)Study completedNCT00154687
What this trial is testing

Weekly TP-HDFL in the Treatment of Advanced TCC

Who this might be right for
Transitional Cell Carcinoma
National Taiwan University Hospital 40
Not applicableStudy completedNCT00216801
What this trial is testing

Relationship of Ochratoxin A to Upper Urologic Cancers

Who this might be right for
Transitional Cell CarcinomaRenal Cell CancerTesticular Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Testing effectiveness (Phase 2)WithdrawnNCT04179110
What this trial is testing

Study of Pembrolizumab and Ramucirumab in Pts With Progressive TCC After Treatment With an Immune Checkpoint Inhibitor

Who this might be right for
Transitional Cell Carcinoma
Yale University
Testing effectiveness (Phase 2)UnknownNCT04671407
What this trial is testing

The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer

Who this might be right for
TCC
Kaplan Medical Center 150
Large-scale testing (Phase 3)Study completedNCT04679103
What this trial is testing

A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation)

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
AO GENERIUM 50
Testing effectiveness (Phase 2)Ended earlyNCT00268450
What this trial is testing

Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery

Who this might be right for
Bladder Cancer
Medical University of South Carolina 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT00756639
What this trial is testing

Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 31
Not applicableActive Not RecruitingNCT00567684
What this trial is testing

Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 133
Testing effectiveness (Phase 2)Study completedNCT00191971
What this trial is testing

2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen

Who this might be right for
Urologic NeoplasmsCarcinoma, Transitional Cell
Eli Lilly and Company 40
Not applicableEnded earlyNCT01563796
What this trial is testing

Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer

Who this might be right for
HematuriaDysuriaBladder Cancer
Medical Diagnostic Laboratories, LLC 1,115
Large-scale testing (Phase 3)WithdrawnNCT04006691
What this trial is testing

Efficacy and Safety of UGN-101 in Recurrent Patients

Who this might be right for
CarcinomaTransitional Cell CarcinomaTransitional Cell Cancer of the Renal Pelvis and Ureter
UroGen Pharma Ltd.
Not applicableLooking for participantsNCT05874921
What this trial is testing

UTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Who this might be right for
Urothelial CarcinomaUrothelial Carcinoma RecurrentUrothelial Carcinoma Ureter+5 more
UroGen Pharma Ltd. 400
Testing effectiveness (Phase 2)Study completedNCT03159143
What this trial is testing

Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract

Who this might be right for
Metastatic Transitional Cell Cancer of the Urothelial Tract
Leonard Appleman 22
Large-scale testing (Phase 3)Study completedNCT00028756
What this trial is testing

Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium

Who this might be right for
Stage III Bladder CancerStage IV Bladder CancerTransitional Cell Carcinoma of the Bladder
European Organisation for Research and Treatment of Cancer - EORTC 285
Testing effectiveness (Phase 2)Study completedNCT00101608
What this trial is testing

Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Who this might be right for
Transitional Cell CarcinomaBladder NeoplasmsKidney Neoplasms+3 more
Bristol-Myers Squibb 150
Testing effectiveness (Phase 2)WithdrawnNCT03935347
What this trial is testing

Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis Urothelial CarcinomaMetastatic Ureter Urothelial Carcinoma+3 more
Roswell Park Cancer Institute
Load More Results